United States Veterinary Stereotactic Radiosurgery System Market By Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife), By Application (Brain Tumours, Spinal Tumours, Other Applications), By End User (Veterinary Hospitals, Veterinary Specialty Clinics, Research and Academic Institutions), By Region, Competition, Forecast & Opportunities, 2020-2030F
Market Overview
The United States Veterinary Stereotactic Radiosurgery System Market was valued at USD 1.18 billion in 2024 and is projected to reach USD 2.03 billion by 2030, growing at a CAGR of 9.44%. Market growth is being fueled by the increasing prevalence of cancer among companion animals and the rising demand for precise, non-invasive treatments. As awareness of advanced therapeutic options grows, pet owners are more inclined to pursue radiosurgery for tumors in the brain, spine, and nasal regions. Technologies such as linear accelerator (LINAC)-based systems, known for their precision and reduced treatment sessions, are gaining popularity. Additional innovations, including image-guided radiotherapy (IGRT), motion management, and emerging techniques like Proton Beam Radiation Therapy (PBRT) and Flash Radiation Therapy, are transforming oncology practices. Integration of AI-assisted diagnostics and software-driven treatment planning is enhancing accuracy, expanding application scope, and reshaping veterinary cancer care delivery in the United States.
Key Market Drivers
Rising Pet Ownership
An increase in pet ownership across the United States is a key factor propelling the growth of the Veterinary Stereotactic Radiosurgery System Market. According to the American Pet Products Association (APPA), as of 2023, approximately 66% of U.S. households—more than 86 million—own a pet, predominantly dogs and cats. As pets are more commonly viewed as family members, there is a growing willingness among owners to pursue specialized and high-quality medical treatments, including advanced oncology procedures. This trend is driving demand for non-invasive technologies such as stereotactic radiosurgery, which is valued for its precision and minimal recovery time.
The surge in veterinary healthcare spending further supports this trend. In 2023, U.S. pet owners spent over USD 38 billion on veterinary care and related services, reflecting growing investment in innovative treatments. Veterinary clinics and specialty hospitals are increasingly adopting technologies like SRS to meet this rising demand and maintain competitive positioning in a market focused on delivering optimal patient outcomes.
Key Market Challenges
Limited Availability of Specialized Veterinary Oncologists
A major constraint on market expansion is the limited pool of specialized veterinary oncologists trained in stereotactic radiosurgery (SRS). These advanced systems require operators with expertise in veterinary oncology and proficiency in handling complex radiological equipment. However, the number of professionals with the requisite skills is currently insufficient to meet growing demand, particularly in regions where veterinary oncology is still an emerging field.
Further compounding this issue is the scarcity of training and certification programs in veterinary radiation oncology. While some educational institutions are introducing relevant curricula, the pace of workforce development lags behind market needs. In less urban or under-resourced regions, the absence of specialists makes it challenging for veterinary clinics to offer SRS, especially given the financial investment required for installation, maintenance, and ongoing professional training. These limitations constrain access to radiosurgery services and hinder the broader adoption of this advanced treatment modality.
Key Market Trends
Growing Adoption of Non-Invasive Treatments
A key trend in the United States Veterinary Stereotactic Radiosurgery System Market is the rising preference for non-invasive therapeutic solutions. With greater awareness of animal well-being and advancements in medical technology, both pet owners and veterinary professionals are turning to minimally invasive methods for treating complex conditions. SRS is gaining traction due to its ability to deliver targeted radiation with minimal damage to surrounding tissue, thereby reducing discomfort and accelerating recovery. This makes it particularly suitable for treating delicate or inoperable tumors in areas like the brain and spine.
This shift is driven by a cultural evolution that views pets as family members deserving of high-quality care. Non-invasive methods like SRS offer reduced hospitalization time, less post-treatment pain, and superior outcomes—benefits that resonate with pet owners. The increasing success of similar techniques in human healthcare has also boosted confidence in their veterinary applications. As clinics invest in advanced radiosurgery systems, they are better positioned to meet the demand for less invasive, more efficient cancer treatments. This trend is expected to continue, supported by growing veterinary healthcare spending and technological innovation.
Key Market Players
Report Scope:
In this report, the United States Veterinary Stereotactic Radiosurgery System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Veterinary Stereotactic Radiosurgery System Market.
Available Customizations:
United States Veterinary Stereotactic Radiosurgery System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The United States Veterinary Stereotactic Radiosurgery System Market was valued at USD 1.18 billion in 2024 and is projected to reach USD 2.03 billion by 2030, growing at a CAGR of 9.44%. Market growth is being fueled by the increasing prevalence of cancer among companion animals and the rising demand for precise, non-invasive treatments. As awareness of advanced therapeutic options grows, pet owners are more inclined to pursue radiosurgery for tumors in the brain, spine, and nasal regions. Technologies such as linear accelerator (LINAC)-based systems, known for their precision and reduced treatment sessions, are gaining popularity. Additional innovations, including image-guided radiotherapy (IGRT), motion management, and emerging techniques like Proton Beam Radiation Therapy (PBRT) and Flash Radiation Therapy, are transforming oncology practices. Integration of AI-assisted diagnostics and software-driven treatment planning is enhancing accuracy, expanding application scope, and reshaping veterinary cancer care delivery in the United States.
Key Market Drivers
Rising Pet Ownership
An increase in pet ownership across the United States is a key factor propelling the growth of the Veterinary Stereotactic Radiosurgery System Market. According to the American Pet Products Association (APPA), as of 2023, approximately 66% of U.S. households—more than 86 million—own a pet, predominantly dogs and cats. As pets are more commonly viewed as family members, there is a growing willingness among owners to pursue specialized and high-quality medical treatments, including advanced oncology procedures. This trend is driving demand for non-invasive technologies such as stereotactic radiosurgery, which is valued for its precision and minimal recovery time.
The surge in veterinary healthcare spending further supports this trend. In 2023, U.S. pet owners spent over USD 38 billion on veterinary care and related services, reflecting growing investment in innovative treatments. Veterinary clinics and specialty hospitals are increasingly adopting technologies like SRS to meet this rising demand and maintain competitive positioning in a market focused on delivering optimal patient outcomes.
Key Market Challenges
Limited Availability of Specialized Veterinary Oncologists
A major constraint on market expansion is the limited pool of specialized veterinary oncologists trained in stereotactic radiosurgery (SRS). These advanced systems require operators with expertise in veterinary oncology and proficiency in handling complex radiological equipment. However, the number of professionals with the requisite skills is currently insufficient to meet growing demand, particularly in regions where veterinary oncology is still an emerging field.
Further compounding this issue is the scarcity of training and certification programs in veterinary radiation oncology. While some educational institutions are introducing relevant curricula, the pace of workforce development lags behind market needs. In less urban or under-resourced regions, the absence of specialists makes it challenging for veterinary clinics to offer SRS, especially given the financial investment required for installation, maintenance, and ongoing professional training. These limitations constrain access to radiosurgery services and hinder the broader adoption of this advanced treatment modality.
Key Market Trends
Growing Adoption of Non-Invasive Treatments
A key trend in the United States Veterinary Stereotactic Radiosurgery System Market is the rising preference for non-invasive therapeutic solutions. With greater awareness of animal well-being and advancements in medical technology, both pet owners and veterinary professionals are turning to minimally invasive methods for treating complex conditions. SRS is gaining traction due to its ability to deliver targeted radiation with minimal damage to surrounding tissue, thereby reducing discomfort and accelerating recovery. This makes it particularly suitable for treating delicate or inoperable tumors in areas like the brain and spine.
This shift is driven by a cultural evolution that views pets as family members deserving of high-quality care. Non-invasive methods like SRS offer reduced hospitalization time, less post-treatment pain, and superior outcomes—benefits that resonate with pet owners. The increasing success of similar techniques in human healthcare has also boosted confidence in their veterinary applications. As clinics invest in advanced radiosurgery systems, they are better positioned to meet the demand for less invasive, more efficient cancer treatments. This trend is expected to continue, supported by growing veterinary healthcare spending and technological innovation.
Key Market Players
- Avante Health Solutions
- Accuray Inc.
- Elekta AB
- Varian Medical Systems Inc.
- PetCure Oncology
- Xstrahl Inc.
- CVS Group
- Medtronic PLC
- Nanovi AS
- Merck & Co. Inc.
Report Scope:
In this report, the United States Veterinary Stereotactic Radiosurgery System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- United States Veterinary Stereotactic Radiosurgery System Market, By Product:
- Gamma Knife
- LINAC
- Proton Beam Radiation Therapy (PBRT)/ Flash-RT
- CyberKnife
- United States Veterinary Stereotactic Radiosurgery System Market, By Application:
- Brain Tumours
- Spinal Tumours
- Other Applications
- United States Veterinary Stereotactic Radiosurgery System Market, By End User:
- Veterinary Hospitals
- Veterinary Specialty Clinics
- Research and Academic Institutions
- United States Veterinary Stereotactic Radiosurgery System Market, By Region:
- North-East
- Mid-West
- West
- South
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Veterinary Stereotactic Radiosurgery System Market.
Available Customizations:
United States Veterinary Stereotactic Radiosurgery System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. UNITED STATES VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife)
5.2.2. By Application (Brain Tumours, Spinal Tumours, Other Applications)
5.2.3. By End User (Veterinary Hospitals, Veterinary Specialty Clinics, Research and Academic Institutions)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH-EAST VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
7. MID-WEST VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
8. WEST VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
9. SOUTH VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. POLICY & REGULATORY LANDSCAPE
13. UNITED STATES ECONOMIC PROFILE
14. UNITED STATES VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET: SWOT ANALYSIS
15. PORTER’S FIVE FORCES ANALYSIS
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. COMPETITIVE LANDSCAPE
16.1. Avante Health Solutions
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. Accuray Inc.
16.3. Elekta AB
16.4. Varian Medical Systems Inc.
16.5. PetCure Oncology
16.6. Xstrahl Inc.
16.7. CVS Group
16.8. Medtronic PLC
16.9. Nanovi AS
16.10. Merck & Co. Inc.
17. STRATEGIC RECOMMENDATIONS
18. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. UNITED STATES VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Gamma Knife, LINAC, Proton Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife)
5.2.2. By Application (Brain Tumours, Spinal Tumours, Other Applications)
5.2.3. By End User (Veterinary Hospitals, Veterinary Specialty Clinics, Research and Academic Institutions)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH-EAST VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By End User
7. MID-WEST VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By End User
8. WEST VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
9. SOUTH VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Merger & Acquisition (If Any)
11.2. Product Launches (If Any)
11.3. Recent Developments
12. POLICY & REGULATORY LANDSCAPE
13. UNITED STATES ECONOMIC PROFILE
14. UNITED STATES VETERINARY STEREOTACTIC RADIOSURGERY SYSTEM MARKET: SWOT ANALYSIS
15. PORTER’S FIVE FORCES ANALYSIS
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. COMPETITIVE LANDSCAPE
16.1. Avante Health Solutions
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (As Reported)
16.1.5. Recent Developments
16.1.6. Key Personnel Details
16.1.7. SWOT Analysis
16.2. Accuray Inc.
16.3. Elekta AB
16.4. Varian Medical Systems Inc.
16.5. PetCure Oncology
16.6. Xstrahl Inc.
16.7. CVS Group
16.8. Medtronic PLC
16.9. Nanovi AS
16.10. Merck & Co. Inc.
17. STRATEGIC RECOMMENDATIONS
18. ABOUT US & DISCLAIMER
